|
Post by babaoriley on May 14, 2014 18:15:00 GMT -5
I left the office early, as I'm going to an early game, which I hope won't be the last for the Kings this year. I was listening to CNBC on Sirius and during the lightning round someone (probably from either here or the Yahoo board), asked his opinion on MNKD, citing that the FDA decision was coming up by Jully 15. Cramer's response was to the effect, yeah, they likely get approval, I didn't think they would, cuz if Pfizer failed with it, how could MNKD succeed, but, yeah, it does look like approval's coming.
He never said anything about liking its business prospects or saying go ahead and buy or hold or add, just that he thought it would be approved - a grudging admission at best.
Pfizer? They had the El caBong, not the Dreamboat. LOL. And Pfizer was filling it with something very different than Afrezza. Reflects the lack of knowledge out there regarding Exubera and Afrezza - I suppose all the better for us in terms of opportunity, but I'd still rather be fully discovered and at $25 today, awaiting a move to $50.
I know, Spiro, you are already awaiting the move to $50!!
|
|
|
Post by bradleysbest on May 14, 2014 20:55:34 GMT -5
As a newbie to this board , I am wondering why Cramer does not like or approve of MNKD?
|
|
|
Post by seanismorris on May 14, 2014 20:57:23 GMT -5
I'm generally indifferent to what Cramer says, but my opinion just took a nose dive. Cramer has been repeatedly asked about MNKD and he obviously didn't spend 5 min. of research to come to his opinion.
Pfizer's product was inhaled insulin 0.5 and Mannkinds Afrezza is insulin 2.0
Cramer you get a F for effort!
|
|
|
Post by 4allthemarbles on May 14, 2014 21:58:52 GMT -5
Bradley- look into Adam F. That's Cramer's little boy. I use to like Cramer, however, the way they have handled themselves regarding Mannkind is despicable.
|
|
|
Post by brentie on May 14, 2014 22:06:17 GMT -5
I'm generally indifferent to what Cramer says, but my opinion just took a nose dive. Cramer has been repeatedly asked about MNKD and he obviously didn't spend 5 min. of research to come to his opinion. Pfizer's product was inhaled insulin 0.5 and Mannkinds Afrezza is insulin 2.0 Cramer you get a F for effort! Cramer's known about Afrezza for years. Here's Cramer interviewing Al three and a half years ago where Al explains the difference between Afrezza and Exubera. afresa.blogspot.com/2010/10/jim-cramer-interview-with-alfred-mann.html
|
|
|
Post by seanismorris on May 15, 2014 0:13:13 GMT -5
I suppose your point is Cramer spent a few minutes to interview Mr. Mann? What I'm hearing is Cramer never did any follow up to try to understand how Exubera is different from Afrezza. Is Cramer making/stating his opinion (today) on Mannkind solely based upon how Mann financed the company? Or, is he having difficultly putting a value on company that has no income? My point is Cramer hasn't done enough work on MNKD to give an educated decision/recommendation. I've heard in the past Cramer say this one (stock) is 'to hard' or to speculative for his show. Those are honest answers, but those are not the answers he is giving in this case.
|
|
|
Post by babaoriley on May 15, 2014 0:29:52 GMT -5
Cramer is not a believer (that's okay, some believe, others don't), and has not done the work to become a believer, or a knowledgeable non-believer (of course, we don't believe the second class of individual exists!). He can't cover all public companies in depth. Problem is, we can spot his shallowness in understanding, but if people don't know MNKD, they can't spot it and just kind of write MNKD off. But, the fact he said he thinks it will get approved, will get some people to look at the stock tomorrow morning, and some of those will buy, figuring, what the heck. As I indicated, it appears his opinion is based on the fact that PFE failed with inhaled insulin, how can Al Mann succeed, where giant PFE, whose biggest issue is erections lasting more than 4 hours (were they talking annually?), failed!
At some point with approval and a partner, my guess is he'll have to look a little closer and once he does, he may become very useful to us.
|
|
|
Post by seanismorris on May 15, 2014 1:08:17 GMT -5
Babaoriley,
I suppose you are right that Cramer mentioning MNKD is a plus, but I'm not sure he will ever have anything to add to the discussion. I think he's a numbers guy, that he is only useful looking at sales and sales projections.
I want some someone that is negative on a stock/company to be knowledgable and negative. That helps in (my) determining if a company is worth the risk.
I've spent many many hours trying to understand diabetes, how it progresses, and how to successfully treat it. And, I'd only consider my knowledge a little beyond basic. ...in addition to Afrezza I've researched different types of treatments, including drugs, artificial pancreas, and glucose monitoring systems, trying to find companies that make 'best in breed' products. Diabetes is incredibly complicated... Love that comment on PFE and ED, by the way. I don't think Cramer will ever do the research, but maybe after Afrezza has been selling for a few years he can look at the numbers.
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 15, 2014 6:50:20 GMT -5
I believe Penn did a research project on Cramer. They concluded if you do the opposite of what he says you are more likely than not to do better. And they figured out Cramer's recommendations did better the week before than they did after he recommended them on his show. And they concluded his sells did worse the weeks before than they did after he recommended them on his show.
They concluded overall he is right less than 50% of the time.
|
|
|
Post by rak5555 on May 15, 2014 7:57:05 GMT -5
That study is where he got the name "47% Cramer". He's just an entertainer w/ a large forehead and a loud annoying voice that never shuts up.
|
|
|
Post by spiro on May 15, 2014 7:59:05 GMT -5
Being honest, I think I've watched Cramer one time for about 5 minutes. IMO opinion he is an entertainer will a 3 word vocabulary. He looks at a chart for 5 seconds and then yells out Buy or Sell and loves to say Booyah. Heck, I could do the same thing on Fox Business News. It would be called the Spiro Show. I would look at a chart for 5 seconds and then yell out Buy or Sell and scream Yassou a couple of dozen times during the show and dance to a little Greek music at times after my favorite stock touts. I would serve Ouzo and Greek pastries to my guests and of course I would talk about MNKD at some time during every show.
|
|
|
Post by liane on May 15, 2014 8:16:51 GMT -5
Could I be a guest on your show?
|
|
|
Post by otherottawaguy on May 15, 2014 8:24:04 GMT -5
OPA...
|
|
|
Post by thekindaguyiyam on May 18, 2014 21:37:05 GMT -5
As a newbie to this board , I am wondering why Cramer does not like or approve of MNKD? That's Cramer all over the place. He deals in commodities and speaks for short interests. If he's saying it will succeed but not giving it praise he's protecting his short interest buddies. Generally a thumbs up from Cramer is a bear raid a day or two later and last 2 to 4 days. He sends signals in body language and endorsement. So the breakfast is at the embassy at what time? I can't come but my kid brother can and I'd like to give him the details of when. Getting that breakfast ends @ 9:30 and then on to the shareholder's meeting. Who's in charge here?! Any info appreciated.
|
|
|
Post by babaoriley on May 19, 2014 11:33:39 GMT -5
Trend says he'll be there at 8:00; I'll be there about that time, too. I'm sure most will plan to be there between 8 and 8:30. There may be a sign at the table, but even if there isn't, it will be obvious to your kid brother or anyone else who we are!
|
|